> top > docs > PMC:7534795 > spans > 1971-8036 > annotations

PMC:7534795 / 1971-8036 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PD-FMA-UBERON

Id Subject Object Predicate Lexical cue fma_id
T43090 735-745 Body_part denotes nucleotide http://purl.org/sig/ont/fma/fma82740
T41330 1665-1688 Body_part denotes central nervous systems http://purl.org/sig/ont/fma/fma55675
T72777 1760-1765 Body_part denotes lungs http://purl.org/sig/ont/fma/fma68877
T16084 1795-1813 Body_part denotes organs and systems http://purl.org/sig/ont/fma/fma7149
T80150 1829-1836 Body_part denotes kidneys http://purl.org/sig/ont/fma/fma7203
T68146 1838-1843 Body_part denotes heart http://purl.org/sig/ont/fma/fma7088
T74654 1845-1858 Body_part denotes blood vessels http://purl.org/sig/ont/fma/fma63183
T81920 1845-1850 Body_part denotes blood http://purl.org/sig/ont/fma/fma9670
T8742 1860-1882 Body_part denotes gastrointestinal tract http://purl.org/sig/ont/fma/fma71132
T68419 1887-1892 Body_part denotes brain http://purl.org/sig/ont/fma/fma50801
T63124 2036-2059 Body_part denotes lower respiratory tract http://purl.org/sig/ont/fma/fma45662
T36357 2137-2141 Body_part denotes lung http://purl.org/sig/ont/fma/fma7195
T22313 2229-2234 Body_part denotes heart http://purl.org/sig/ont/fma/fma7088
T26828 3051-3060 Body_part denotes Melatonin http://purl.org/sig/ont/fma/fma74644
T62683 3190-3195 Body_part denotes heart http://purl.org/sig/ont/fma/fma7088
T69623 3259-3272 Body_part denotes interleukin-6 http://purl.org/sig/ont/fma/fma264829
T2300 3405-3413 Body_part denotes cytokine http://purl.org/sig/ont/fma/fma84050
T70564 3728-3733 Body_part denotes organ http://purl.org/sig/ont/fma/fma67498
T71556 4076-4089 Body_part denotes interleukin-1 http://purl.org/sig/ont/fma/fma86583
T41271 4113-4117 Body_part denotes IL-1 http://purl.org/sig/ont/fma/fma86583
T45585 4138-4145 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T90573 4193-4201 Body_part denotes cytokine http://purl.org/sig/ont/fma/fma84050
T84940 4318-4329 Body_part denotes Granulocyte http://purl.org/sig/ont/fma/fma62854
T2963 4330-4340 Body_part denotes macrophage http://purl.org/sig/ont/fma/fma63261
T89453 4371-4374 Body_part denotes CSF http://purl.org/sig/ont/fma/fma20935
T80835 4392-4395 Body_part denotes CSF http://purl.org/sig/ont/fma/fma20935
T16035 4442-4453 Body_part denotes macrophages http://purl.org/sig/ont/fma/fma63261
T75061 4517-4520 Body_part denotes CSF http://purl.org/sig/ont/fma/fma20935
T35610 4568-4571 Body_part denotes CSF http://purl.org/sig/ont/fma/fma20935
T79976 4597-4606 Body_part denotes cytokines http://purl.org/sig/ont/fma/fma84050
T70672 4646-4654 Body_part denotes cytokine http://purl.org/sig/ont/fma/fma84050
T41412 4744-4753 Body_part denotes cytokines http://purl.org/sig/ont/fma/fma84050
T31184 5377-5382 Body_part denotes heart http://purl.org/sig/ont/fma/fma7088
T42589 5770-5791 Body_part denotes endoplasmic reticulum http://purl.org/sig/ont/fma/fma63842
T72751 5793-5795 Body_part denotes ER http://purl.org/sig/ont/fma/fma63842
T4655 5977-5988 Body_part denotes fatty acids http://purl.org/sig/ont/fma/fma82738

LitCovid-PD-UBERON

Id Subject Object Predicate Lexical cue uberon_id
T4 1665-1688 Body_part denotes central nervous systems http://purl.obolibrary.org/obo/UBERON_0001017
T5 1795-1801 Body_part denotes organs http://purl.obolibrary.org/obo/UBERON_0000062
T6 1838-1858 Body_part denotes heart, blood vessels http://purl.obolibrary.org/obo/UBERON_0003498
T7 1838-1843 Body_part denotes heart http://purl.obolibrary.org/obo/UBERON_0000948
T8 1845-1850 Body_part denotes blood http://purl.obolibrary.org/obo/UBERON_0000178
T9 1851-1858 Body_part denotes vessels http://purl.obolibrary.org/obo/UBERON_0000055
T10 1887-1892 Body_part denotes brain http://purl.obolibrary.org/obo/UBERON_0000955
T11 2036-2059 Body_part denotes lower respiratory tract http://purl.obolibrary.org/obo/UBERON_0001558
T12 2042-2059 Body_part denotes respiratory tract http://purl.obolibrary.org/obo/UBERON_0000065
T13 2137-2141 Body_part denotes lung http://purl.obolibrary.org/obo/UBERON_0002048
T14 2229-2234 Body_part denotes heart http://purl.obolibrary.org/obo/UBERON_0000948
T15 3190-3195 Body_part denotes heart http://purl.obolibrary.org/obo/UBERON_0000948
T16 3728-3733 Body_part denotes organ http://purl.obolibrary.org/obo/UBERON_0000062
T17 5377-5382 Body_part denotes heart http://purl.obolibrary.org/obo/UBERON_0000948

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T15 79-116 Disease denotes severe and acute respiratory syndrome http://purl.obolibrary.org/obo/MONDO_0005091
T16 130-138 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T17 262-270 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T18 288-298 Disease denotes infectious http://purl.obolibrary.org/obo/MONDO_0005550
T19 653-661 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T20 701-709 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T21 783-830 Disease denotes severe acute respiratory syndrome coronavirus 2 http://purl.obolibrary.org/obo/MONDO_0100096
T22 783-816 Disease denotes severe acute respiratory syndrome http://purl.obolibrary.org/obo/MONDO_0005091
T23 832-840 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T24 1011-1019 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T25 1110-1119 Disease denotes pneumonia http://purl.obolibrary.org/obo/MONDO_0005249
T26 1197-1205 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T27 1304-1312 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T28 1727-1735 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T29 1956-1964 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T30 2036-2067 Disease denotes lower respiratory tract disease http://purl.obolibrary.org/obo/MONDO_0000270
T31 2131-2148 Disease denotes acute lung injury http://purl.obolibrary.org/obo/MONDO_0006502|http://purl.obolibrary.org/obo/MONDO_0015796
T33 2142-2148 Disease denotes injury http://purl.obolibrary.org/obo/MONDO_0021178
T34 2150-2153 Disease denotes ALI http://purl.obolibrary.org/obo/MONDO_0006502
T35 2156-2191 Disease denotes acute respiratory distress syndrome http://purl.obolibrary.org/obo/MONDO_0006502
T36 2162-2191 Disease denotes respiratory distress syndrome http://purl.obolibrary.org/obo/MONDO_0009971
T37 2193-2197 Disease denotes ARDS http://purl.obolibrary.org/obo/MONDO_0006502
T38 2200-2219 Disease denotes respiratory failure http://purl.obolibrary.org/obo/MONDO_0021113
T39 2229-2242 Disease denotes heart failure http://purl.obolibrary.org/obo/MONDO_0005252
T40 2244-2246 Disease denotes HF http://purl.obolibrary.org/obo/MONDO_0005252
T41 2252-2273 Disease denotes sudden cardiac arrest http://purl.obolibrary.org/obo/MONDO_0007264
T42 2259-2273 Disease denotes cardiac arrest http://purl.obolibrary.org/obo/MONDO_0000745
T43 2612-2620 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T44 2826-2834 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T45 3006-3014 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T46 3105-3119 Disease denotes cardiomyopathy http://purl.obolibrary.org/obo/MONDO_0004994
T47 3138-3159 Disease denotes myocardial infarction http://purl.obolibrary.org/obo/MONDO_0005068
T48 3161-3175 Disease denotes cardiomyopathy http://purl.obolibrary.org/obo/MONDO_0004994
T49 3177-3204 Disease denotes hypertensive heart diseases http://purl.obolibrary.org/obo/MONDO_0001302
T50 3210-3232 Disease denotes pulmonary hypertension http://purl.obolibrary.org/obo/MONDO_0005149
T51 3220-3232 Disease denotes hypertension http://purl.obolibrary.org/obo/MONDO_0005044
T52 3674-3682 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T53 3765-3771 Disease denotes injury http://purl.obolibrary.org/obo/MONDO_0021178
T54 4456-4464 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T55 4770-4778 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T56 5073-5081 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T57 5222-5230 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T58 5316-5328 Disease denotes hypertension http://purl.obolibrary.org/obo/MONDO_0005044
T59 5330-5345 Disease denotes atherosclerosis http://purl.obolibrary.org/obo/MONDO_0005311
T60 5357-5369 Disease denotes inflammation http://purl.obolibrary.org/obo/MONDO_0021166
T61 5377-5390 Disease denotes heart failure http://purl.obolibrary.org/obo/MONDO_0005252
T62 5400-5412 Disease denotes inflammation http://purl.obolibrary.org/obo/MONDO_0021166
T63 5418-5437 Disease denotes myocardial ischemia http://purl.obolibrary.org/obo/MONDO_0024644
T64 5429-5437 Disease denotes ischemia http://purl.obolibrary.org/obo/MONDO_0005053
T65 5856-5868 Disease denotes inflammation http://purl.obolibrary.org/obo/MONDO_0021166

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T88816 559-566 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes Viruses
T19128 1098-1099 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T18892 1346-1358 http://purl.obolibrary.org/obo/OBI_0000245 denotes Organization
T18621 1362-1363 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T5066 1580-1587 http://purl.obolibrary.org/obo/NCBITaxon_33208 denotes animals
T11010 1592-1598 http://purl.obolibrary.org/obo/NCBITaxon_9606 denotes humans
T91245 1665-1688 http://purl.obolibrary.org/obo/UBERON_0001017 denotes central nervous systems
T41100 1665-1688 http://www.ebi.ac.uk/efo/EFO_0000302 denotes central nervous systems
T28423 1665-1688 http://www.ebi.ac.uk/efo/EFO_0000908 denotes central nervous systems
T54681 1695-1697 http://purl.obolibrary.org/obo/CLO_0001022 denotes Li
T54688 1695-1697 http://purl.obolibrary.org/obo/CLO_0007314 denotes Li
T28843 1760-1765 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lungs
T98322 1795-1813 http://purl.obolibrary.org/obo/UBERON_0000467 denotes organs and systems
T76276 1829-1836 http://purl.obolibrary.org/obo/UBERON_0002113 denotes kidneys
T59650 1829-1836 http://www.ebi.ac.uk/efo/EFO_0000927 denotes kidneys
T46669 1829-1836 http://www.ebi.ac.uk/efo/EFO_0000929 denotes kidneys
T10398 1838-1843 http://purl.obolibrary.org/obo/UBERON_0000948 denotes heart
T37309 1838-1843 http://purl.obolibrary.org/obo/UBERON_0007100 denotes heart
T60359 1838-1843 http://purl.obolibrary.org/obo/UBERON_0015228 denotes heart
T83927 1838-1843 http://www.ebi.ac.uk/efo/EFO_0000815 denotes heart
T95767 1845-1858 http://purl.obolibrary.org/obo/UBERON_0001981 denotes blood vessels
T43385 1845-1858 http://www.ebi.ac.uk/efo/EFO_0000817 denotes blood vessels
T54345 1860-1882 http://purl.obolibrary.org/obo/UBERON_0005409 denotes gastrointestinal tract
T58218 1887-1892 http://purl.obolibrary.org/obo/UBERON_0000955 denotes brain
T72303 1887-1892 http://www.ebi.ac.uk/efo/EFO_0000302 denotes brain
T28712 2036-2059 http://purl.obolibrary.org/obo/UBERON_0001558 denotes lower respiratory tract
T81723 2137-2141 http://purl.obolibrary.org/obo/UBERON_0002048 denotes lung
T29985 2137-2141 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lung
T97169 2229-2234 http://purl.obolibrary.org/obo/UBERON_0000948 denotes heart
T97037 2229-2234 http://purl.obolibrary.org/obo/UBERON_0007100 denotes heart
T58825 2229-2234 http://purl.obolibrary.org/obo/UBERON_0015228 denotes heart
T17826 2229-2234 http://www.ebi.ac.uk/efo/EFO_0000815 denotes heart
T25626 2281-2282 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T20269 3122-3125 http://purl.obolibrary.org/obo/CLO_0051582 denotes Has
T32303 3190-3195 http://purl.obolibrary.org/obo/UBERON_0000948 denotes heart
T86034 3190-3195 http://purl.obolibrary.org/obo/UBERON_0007100 denotes heart
T68915 3190-3195 http://purl.obolibrary.org/obo/UBERON_0015228 denotes heart
T41295 3190-3195 http://www.ebi.ac.uk/efo/EFO_0000815 denotes heart
T78016 3259-3272 http://purl.obolibrary.org/obo/PR_000001393 denotes interleukin-6
T85990 3728-3733 http://purl.obolibrary.org/obo/UBERON_0003103 denotes organ
T15304 3928-3937 http://purl.obolibrary.org/obo/SO_0000418 denotes signaling
T98618 4076-4089 http://purl.obolibrary.org/obo/PR_000001091 denotes interleukin-1
T66694 4102-4103 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T23727 4405-4406 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T5199 4429-4438 http://purl.obolibrary.org/obo/SO_0000418 denotes signaling
T73249 5377-5382 http://purl.obolibrary.org/obo/UBERON_0000948 denotes heart
T2074 5377-5382 http://purl.obolibrary.org/obo/UBERON_0007100 denotes heart
T35465 5377-5382 http://purl.obolibrary.org/obo/UBERON_0015228 denotes heart
T11230 5377-5382 http://www.ebi.ac.uk/efo/EFO_0000815 denotes heart

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T29 735-745 Chemical denotes nucleotide http://purl.obolibrary.org/obo/CHEBI_36976
T30 1695-1697 Chemical denotes Li http://purl.obolibrary.org/obo/CHEBI_30145
T31 2244-2246 Chemical denotes HF http://purl.obolibrary.org/obo/CHEBI_141438|http://purl.obolibrary.org/obo/CHEBI_29228
T33 2481-2496 Chemical denotes corticosteroids http://purl.obolibrary.org/obo/CHEBI_50858
T34 2498-2507 Chemical denotes antiviral http://purl.obolibrary.org/obo/CHEBI_22587
T35 2918-2927 Chemical denotes Vitamin C http://purl.obolibrary.org/obo/CHEBI_21241|http://purl.obolibrary.org/obo/CHEBI_29073|http://purl.obolibrary.org/obo/CHEBI_38290
T38 2918-2925 Chemical denotes Vitamin http://purl.obolibrary.org/obo/CHEBI_33229
T39 3051-3060 Chemical denotes Melatonin http://purl.obolibrary.org/obo/CHEBI_16796
T40 3293-3295 Chemical denotes IL http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072
T42 3326-3328 Chemical denotes IL http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072
T44 3353-3355 Chemical denotes IL http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072
T46 3433-3435 Chemical denotes IL http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072
T48 3573-3583 Chemical denotes etanercept http://purl.obolibrary.org/obo/CHEBI_4875
T49 3817-3827 Chemical denotes inhibitors http://purl.obolibrary.org/obo/CHEBI_35222
T50 3843-3854 Chemical denotes tofacitinib http://purl.obolibrary.org/obo/CHEBI_71200
T51 3923-3925 Chemical denotes IL http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072
T53 4113-4115 Chemical denotes IL http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072
T55 4127-4137 Chemical denotes antagonist http://purl.obolibrary.org/obo/CHEBI_48706
T56 4138-4145 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T57 4368-4370 Chemical denotes GM http://purl.obolibrary.org/obo/CHEBI_74120
T58 4389-4391 Chemical denotes GM http://purl.obolibrary.org/obo/CHEBI_74120
T59 4514-4516 Chemical denotes GM http://purl.obolibrary.org/obo/CHEBI_74120
T60 4565-4567 Chemical denotes GM http://purl.obolibrary.org/obo/CHEBI_74120
T61 4960-4971 Chemical denotes antagonists http://purl.obolibrary.org/obo/CHEBI_48706
T62 5108-5124 Chemical denotes N-acetylcysteine http://purl.obolibrary.org/obo/CHEBI_28939
T63 5110-5124 Chemical denotes acetylcysteine http://purl.obolibrary.org/obo/CHEBI_22198
T64 5126-5129 Chemical denotes NAC http://purl.obolibrary.org/obo/CHEBI_28939|http://purl.obolibrary.org/obo/CHEBI_7421
T66 5138-5145 Chemical denotes oxidant http://purl.obolibrary.org/obo/CHEBI_63248
T67 5182-5185 Chemical denotes NAC http://purl.obolibrary.org/obo/CHEBI_28939|http://purl.obolibrary.org/obo/CHEBI_7421
T69 5201-5209 Chemical denotes adjuvant http://purl.obolibrary.org/obo/CHEBI_60809
T70 5295-5298 Chemical denotes NAC http://purl.obolibrary.org/obo/CHEBI_28939|http://purl.obolibrary.org/obo/CHEBI_7421
T72 5461-5463 Chemical denotes La http://purl.obolibrary.org/obo/CHEBI_33336
T73 5530-5537 Chemical denotes epoxide http://purl.obolibrary.org/obo/CHEBI_32955
T74 5554-5564 Chemical denotes inhibitors http://purl.obolibrary.org/obo/CHEBI_35222
T75 5567-5592 Chemical denotes Epoxyeicosatrienoic acids http://purl.obolibrary.org/obo/CHEBI_64007
T76 5587-5592 Chemical denotes acids http://purl.obolibrary.org/obo/CHEBI_37527
T77 5594-5598 Chemical denotes EETs http://purl.obolibrary.org/obo/CHEBI_64007
T78 5739-5749 Chemical denotes eicosanoid http://purl.obolibrary.org/obo/CHEBI_23899
T79 5932-5934 Chemical denotes Co http://purl.obolibrary.org/obo/CHEBI_27638
T80 5954-5964 Chemical denotes inhibitors http://purl.obolibrary.org/obo/CHEBI_35222
T81 5969-5988 Chemical denotes omega-3 fatty acids http://purl.obolibrary.org/obo/CHEBI_25681
T82 5977-5988 Chemical denotes fatty acids http://purl.obolibrary.org/obo/CHEBI_35366
T83 5983-5988 Chemical denotes acids http://purl.obolibrary.org/obo/CHEBI_37527

LitCovid-PD-GO-BP

Id Subject Object Predicate Lexical cue
T4456 3928-3937 http://purl.obolibrary.org/obo/GO_0023052 denotes signaling
T38785 4429-4438 http://purl.obolibrary.org/obo/GO_0023052 denotes signaling
T79378 5357-5369 http://purl.obolibrary.org/obo/GO_0006954 denotes inflammation
T50858 5400-5412 http://purl.obolibrary.org/obo/GO_0006954 denotes inflammation
T54320 5549-5552 http://purl.obolibrary.org/obo/GO_0033885 denotes sEH
T86858 5701-5704 http://purl.obolibrary.org/obo/GO_0033885 denotes sEH
T99650 5856-5868 http://purl.obolibrary.org/obo/GO_0006954 denotes inflammation
T10292 5950-5953 http://purl.obolibrary.org/obo/GO_0033885 denotes sEH

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T12 0-15 Sentence denotes 1 Introduction
T13 16-256 Sentence denotes The first outbreak of the novel coronaviruses was triggered by severe and acute respiratory syndrome coronavirus (SARS-CoV) in China in 2002, which was followed in 2012 by the Middle East respiratory syndrome-related coronavirus (MERS-CoV).
T14 257-484 Sentence denotes Both SARS-CoV and MERS-CoV are infectious, lethal and accounted for thousands of deaths over the past two decades (de Wit, van Doremalen, Falzarano, & Munster, 2016; Zaki, van Boheemen, Bestebroer, Osterhaus, & Fouchier, 2012).
T15 485-987 Sentence denotes The Coronavirus Study Group of the International Committee on Taxonomy of Viruses evaluated the novelty of the coronavirus responsible for the recent outbreak in 2019 (COVID-19) and formally considered it related to SARS-CoV, as they share about 79% nucleotide identity and accordingly named it as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) or 2019-novel coronavirus (Coronaviridae Study Group of the International Committee on Taxonomy of, 2020; Ren et al., 2020; Zhou et al., 2020).
T16 988-1177 Sentence denotes The recent eruption of COVID-19 was first reported in Wuhan, Hubei Province, China in late December 2019 when a series of pneumonia cases of unknown cause were detected (Wang et al., 2020).
T17 1178-1274 Sentence denotes Highly contagious, COVID-19 spread rapidly throughout China and most countries across the world.
T18 1275-1553 Sentence denotes On March 11th, the spread of COVID-19 was declared by the World Health Organization as a global pandemic and by October 9, 2020, the cumulative number of diagnosed patients internationally was 36,577,872 with 1,062,677 global deaths (https://coronavirus.jhu.edu/map.html, 2020).
T19 1554-1712 Sentence denotes Coronaviruses infect both animals and humans affecting their respiratory, gastrointestinal, cardiovascular and central nervous systems (Cui, Li, & Shi, 2019).
T20 1713-1943 Sentence denotes Consistently, SARS-CoV-2 primarily targets the lungs but it can affect many other organs and systems, including the kidneys, heart, blood vessels, gastrointestinal tract and brain (Wadman, Couzin-Frankel, Kaiser, & Matacic, 2020).
T21 1944-2068 Sentence denotes Symptoms of COVID-19 are manifested as myalgia, fatigue, fever and dry cough, together with lower respiratory tract disease.
T22 2069-2292 Sentence denotes In some cases, the severe progression of the disease leads to acute lung injury (ALI), acute respiratory distress syndrome (ARDS), respiratory failure, sepsis, heart failure (HF) and sudden cardiac arrest within a few days.
T23 2293-2456 Sentence denotes Importantly, there is significant morbidity and mortality in the elderly and individuals with underlying health conditions (Chen et al., 2020; Huang et al., 2020).
T24 2457-2731 Sentence denotes Although treatment with corticosteroids, antiviral therapy and mechanical respiratory support have been employed, there is still no specific treatment for COVID-19 and therefore supportive care is of paramount importance (Huang et al., 2020; Wu & McGoogan, 2020) (Table 1 ).
T25 2732-2844 Sentence denotes Table 1 Overview of some proposed pharmacological agents with potential beneficial effects in COVID-19 patients.
T26 2845-2894 Sentence denotes Pharmacological intervention Conclusion Reference
T27 2895-3050 Sentence denotes Antioxidants including Vitamin C and E • Antioxidant effects may ameliorate cardiac injuries of critically ill COVID-19 patients (Wang, Zhang, & Bai, 2020)
T28 3051-3119 Sentence denotes Melatonin • May have preventive effect against septic cardiomyopathy
T29 3120-3253 Sentence denotes • Has benefits in myocardial infarction, cardiomyopathy, hypertensive heart diseases, and pulmonary hypertension (Zhang et al., 2020)
T30 3254-3536 Sentence denotes Anti-interleukin-6 • Tocilizumab (anti-IL-6 receptor), siltuximab (anti-IL-6), and sirukumab (anti-IL-6) are proposed as possible treatments to manage cytokine storm and elevated IL-6 levels (Akhmerov & Marban, 2020; Hendren, Drazner, Bozkurt, & Cooper Jr., 2020; Rizk et al., 2020)
T31 3537-3797 Sentence denotes Anti-TNFα • Infliximab, adalimumab, etanercept, golimumab, certolizumab as TNFα neutralizing therapies suggested as potential agents for COVID-19 hyperinflammatory state which may ameliorate organ damage including acute cardiac injury (Convertino et al., 2020)
T32 3798-4070 Sentence denotes Janus kinase (JAK) inhibitors • Ruxolitinib, tofacitinib, baricitinib are proposed to be beneficial in controlling excessive IL-6 signaling through STAT-1 and STAT-3 pathways (Alijotas-Reig et al., 2020; Convertino et al., 2020; Richardson et al., 2020; Rizk et al., 2020)
T33 4071-4317 Sentence denotes Anti-interleukin-1 • Anakinra, a modified IL-1 receptor antagonist protein, is suggested to have therapeutic potential in cytokine storm, given its effectiveness on patient survival in severe sepsis (Alijotas-Reig et al., 2020; Rizk et al., 2020)
T34 4318-4453 Sentence denotes Granulocyte-macrophage-colony stimulating factor (GM-CSF) inhibition • GM-CSF can play a pro-inflammatory role signaling to macrophages
T35 4454-4527 Sentence denotes • COVID-19 patients have been demonstrated to have elevated GM-CSF levels
T36 4528-4680 Sentence denotes • Literature proposes that targeting GM-CSF upstream of inflammatory cytokines ex. gimsilumab, may be useful to blunt cytokine storm (Rizk et al., 2020)
T37 4681-4913 Sentence denotes Statins • Anti-inflammatory properties, including reduction in cytokines, may benefit in COVID-19 hyperinflammatory states in addition to their conventional cardioprotective properties (Alijotas-Reig et al., 2020; Rizk et al., 2020)
T38 4914-5107 Sentence denotes ACEi/ARBs • Proposed that treatment with RAAS antagonists may theoretically be beneficial by upregulating ACE2 and compensating for ACE2 receptors lost due to COVID-19 (Akhmerov & Marban, 2020)
T39 5108-5273 Sentence denotes N-acetylcysteine (NAC) • Anti-oxidant and anti-inflammatory properties of NAC proposed as an adjuvant therapy for COVID-19 and secondary cardiovascular complications
T40 5274-5505 Sentence denotes • Suggested role for NAC in prevention of hypertension, atherosclerosis-associated inflammation, acute heart failure, thrombo-inflammation, and myocardial ischemia (De Flora, Balansky, & La Maestra, 2020; Guglielmetti et al., 2020)
T41 5506-5657 Sentence denotes Eicosanoids and soluble epoxide hydrolase (sEH) inhibitors • Epoxyeicosatrienoic acids (EETs) are cardioprotective, anti-inflammatory and pro-resolving
T42 5658-5803 Sentence denotes • Inhibition of their metabolizing enzyme, sEH, may be beneficial by maintaining eicosanoid levels and reducing endoplasmic reticulum (ER) stress
T43 5804-5929 Sentence denotes • Potential to limit inflammatory storm and resolve inflammation in addition to their established cardioprotective properties
T44 5930-6065 Sentence denotes • Co-treatment with sEH inhibitors and omega-3 fatty acids may provide synergistic effects (Hammock, Wang, Gilligan, & Panigrahy, 2020)

LitCovid-PD-HP

Id Subject Object Predicate Lexical cue hp_id
T5 1110-1119 Phenotype denotes pneumonia http://purl.obolibrary.org/obo/HP_0002090
T6 1983-1990 Phenotype denotes myalgia http://purl.obolibrary.org/obo/HP_0003326
T7 1992-1999 Phenotype denotes fatigue http://purl.obolibrary.org/obo/HP_0012378
T8 2001-2006 Phenotype denotes fever http://purl.obolibrary.org/obo/HP_0001945
T9 2011-2020 Phenotype denotes dry cough http://purl.obolibrary.org/obo/HP_0031246
T10 2131-2148 Phenotype denotes acute lung injury http://www.orpha.net/ORDO/Orphanet_178320
T11 2150-2153 Phenotype denotes ALI http://www.orpha.net/ORDO/Orphanet_178320
T12 2162-2182 Phenotype denotes respiratory distress http://purl.obolibrary.org/obo/HP_0002098
T13 2200-2219 Phenotype denotes respiratory failure http://purl.obolibrary.org/obo/HP_0002878
T14 2221-2227 Phenotype denotes sepsis http://purl.obolibrary.org/obo/HP_0100806
T15 2229-2242 Phenotype denotes heart failure http://purl.obolibrary.org/obo/HP_0001635
T16 2244-2246 Phenotype denotes HF http://purl.obolibrary.org/obo/HP_0001635
T17 2252-2273 Phenotype denotes sudden cardiac arrest http://purl.obolibrary.org/obo/HP_0031628
T18 3105-3119 Phenotype denotes cardiomyopathy http://purl.obolibrary.org/obo/HP_0001638
T19 3138-3159 Phenotype denotes myocardial infarction http://purl.obolibrary.org/obo/HP_0001658
T20 3161-3175 Phenotype denotes cardiomyopathy http://purl.obolibrary.org/obo/HP_0001638
T21 3220-3232 Phenotype denotes hypertension http://purl.obolibrary.org/obo/HP_0000822
T22 3405-3419 Phenotype denotes cytokine storm http://purl.obolibrary.org/obo/HP_0033041
T23 4193-4207 Phenotype denotes cytokine storm http://purl.obolibrary.org/obo/HP_0033041
T24 4263-4269 Phenotype denotes sepsis http://purl.obolibrary.org/obo/HP_0100806
T25 4646-4660 Phenotype denotes cytokine storm http://purl.obolibrary.org/obo/HP_0033041
T26 5316-5328 Phenotype denotes hypertension http://purl.obolibrary.org/obo/HP_0000822
T27 5330-5345 Phenotype denotes atherosclerosis http://purl.obolibrary.org/obo/HP_0002621
T28 5377-5390 Phenotype denotes heart failure http://purl.obolibrary.org/obo/HP_0001635

2_test

Id Subject Object Predicate Lexical cue
33031856-27344959-84038790 417-421 27344959 denotes 2016
33031856-23075143-84038791 478-482 23075143 denotes 2012
33031856-32004165-84038792 962-966 32004165 denotes 2020
33031856-32015507-84038793 981-985 32015507 denotes 2020
33031856-32031570-84038794 1171-1175 32031570 denotes 2020
33031856-30531947-84038795 1706-1710 30531947 denotes 2019
33031856-32327580-84038796 1937-1941 32327580 denotes 2020
33031856-32007143-84038797 2430-2434 32007143 denotes 2020
33031856-31986264-84038798 2450-2454 31986264 denotes 2020
33031856-31986264-84038799 2693-2697 31986264 denotes 2020
33031856-32091533-84038800 2714-2718 32091533 denotes 2020
33031856-32321655-84038801 3045-3049 32321655 denotes 2020
33031856-32252591-84038802 3465-3469 32252591 denotes 2020
33031856-32297796-84038803 3512-3516 32297796 denotes 2020
33031856-32696108-84038804 3531-3535 32696108 denotes 2020
33031856-32527304-84038805 3792-3796 32527304 denotes 2020
33031856-32527304-84038806 4021-4025 32527304 denotes 2020
33031856-32032529-84038807 4046-4050 32032529 denotes 2020
33031856-32696108-84038808 4065-4069 32696108 denotes 2020
33031856-32696108-84038809 4312-4316 32696108 denotes 2020
33031856-32696108-84038810 4675-4679 32696108 denotes 2020
33031856-32696108-84038811 4312-4316 32696108 denotes 2020
33031856-32252591-84038812 5102-5106 32252591 denotes 2020
33031856-32560665-84038813 5500-5504 32560665 denotes 2020
33031856-32650004-84038814 6060-6064 32650004 denotes 2020

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
85 42-61 Species denotes novel coronaviruses Tax:2697049
86 117-128 Species denotes coronavirus Tax:11118
87 130-138 Species denotes SARS-CoV Tax:694009
88 192-244 Species denotes Middle East respiratory syndrome-related coronavirus Tax:1335626
89 246-254 Species denotes MERS-CoV Tax:1335626
90 262-270 Species denotes SARS-CoV Tax:694009
91 275-283 Species denotes MERS-CoV Tax:1335626
92 489-500 Species denotes Coronavirus Tax:11118
93 596-607 Species denotes coronavirus Tax:11118
94 701-709 Species denotes SARS-CoV Tax:694009
95 783-830 Species denotes severe acute respiratory syndrome coronavirus 2 Tax:2697049
96 832-842 Species denotes SARS-CoV-2 Tax:2697049
97 847-869 Species denotes 2019-novel coronavirus Tax:2697049
98 1439-1447 Species denotes patients Tax:9606
99 338-344 Disease denotes deaths MESH:D003643
100 653-661 Disease denotes COVID-19 MESH:C000657245
101 1011-1019 Disease denotes COVID-19 MESH:C000657245
102 1110-1119 Disease denotes pneumonia MESH:D011014
103 1197-1205 Disease denotes COVID-19 MESH:C000657245
104 1304-1312 Disease denotes COVID-19 MESH:C000657245
156 3259-3272 Gene denotes interleukin-6 Gene:3569
157 3326-3330 Gene denotes IL-6 Gene:3569
158 3353-3357 Gene denotes IL-6 Gene:3569
159 3433-3437 Gene denotes IL-6 Gene:3569
160 3542-3546 Gene denotes TNFα Gene:7124
161 3612-3616 Gene denotes TNFα Gene:7124
162 3923-3927 Gene denotes IL-6 Gene:3569
163 3946-3952 Gene denotes STAT-1 Gene:6772
164 3957-3963 Gene denotes STAT-3 Gene:6774
165 4113-4137 Gene denotes IL-1 receptor antagonist Gene:3557
166 4318-4366 Gene denotes Granulocyte-macrophage-colony stimulating factor Gene:1437
167 4368-4374 Gene denotes GM-CSF Gene:1437
168 4514-4520 Gene denotes GM-CSF Gene:1437
169 4565-4571 Gene denotes GM-CSF Gene:1437
176 4076-4089 Gene denotes interleukin-1 Gene:3552
177 3015-3023 Species denotes patients Tax:9606
178 4236-4243 Species denotes patient Tax:9606
179 4465-4473 Species denotes patients Tax:9606
180 4389-4395 Gene denotes GM-CSF Gene:1437
181 2918-2927 Chemical denotes Vitamin C MESH:D001205
182 3051-3060 Chemical denotes Melatonin MESH:D008550
183 2971-2987 Disease denotes cardiac injuries MESH:D006331
184 2991-3005 Disease denotes critically ill MESH:D016638
185 3006-3014 Disease denotes COVID-19 MESH:C000657245
186 3098-3119 Disease denotes septic cardiomyopathy MESH:D009202
187 3138-3159 Disease denotes myocardial infarction MESH:D009203
188 3161-3175 Disease denotes cardiomyopathy MESH:D009202
189 3177-3204 Disease denotes hypertensive heart diseases MESH:D006973
190 3210-3232 Disease denotes pulmonary hypertension MESH:D006976
191 3674-3682 Disease denotes COVID-19 MESH:C000657245
192 3757-3803 Disease denotes cardiac injury (Convertino et al., 2020) Janus MESH:D006331
193 4263-4269 Disease denotes sepsis MESH:D018805
194 4442-4464 Disease denotes macrophages • COVID-19 MESH:C000657245
195 4611-4621 Disease denotes gimsilumab
208 2835-2843 Species denotes patients Tax:9606
209 2826-2834 Disease denotes COVID-19 MESH:C000657245
228 1554-1567 Species denotes Coronaviruses Tax:11118
229 1592-1598 Species denotes humans Tax:9606
230 1727-1737 Species denotes SARS-CoV-2 Tax:2697049
231 1956-1964 Disease denotes COVID-19 MESH:C000657245
232 1983-1990 Disease denotes myalgia MESH:D063806
233 1992-1999 Disease denotes fatigue MESH:D005221
234 2001-2006 Disease denotes fever MESH:D005334
235 2011-2020 Disease denotes dry cough MESH:D003371
236 2042-2067 Disease denotes respiratory tract disease MESH:D012140
237 2137-2148 Disease denotes lung injury MESH:D055370
238 2156-2191 Disease denotes acute respiratory distress syndrome MESH:D012128
239 2193-2197 Disease denotes ARDS MESH:D012128
240 2200-2219 Disease denotes respiratory failure MESH:D012131
241 2221-2227 Disease denotes sepsis MESH:D018805
242 2229-2242 Disease denotes heart failure MESH:D006333
243 2259-2273 Disease denotes cardiac arrest MESH:D006323
244 2341-2350 Disease denotes mortality MESH:D003643
245 2612-2620 Disease denotes COVID-19 MESH:C000657245